Glow Stack kalkulator

What Is the Glow Stack?

The Glow Stack is a carefully formulated peptide combination designed to support skin rejuvenation and accelerated tissue repair. It pairs two well-studied bioactive peptides — GHK-Cu (copper tripeptide-1) and BPC-157 (Body Protection Compound-157) — into a single daily protocol that addresses skin quality from two complementary angles: structural regeneration and anti-inflammatory repair.

GHK-Cu is one of the most extensively researched copper peptides in the field of dermatology and anti-aging science. It naturally occurs in human plasma, saliva, and urine, with levels declining significantly after the age of 60. Its primary role is to stimulate collagen and elastin production in the dermis, promote antioxidant defenses, and activate genes associated with tissue remodeling and wound repair. BPC-157, a synthetic peptide derived from a protective protein found in gastric juice, has demonstrated potent effects on wound healing, vascular growth, and the reduction of systemic inflammation — mechanisms that translate directly into improved skin quality when used as part of a topical or subcutaneous protocol.

Together, the Glow Stack is used by biohackers, longevity-focused practitioners, and individuals seeking visible improvements in skin texture, elasticity, and overall radiance — without relying solely on topical cosmetics that act only at the surface level.

You can find the Glow Stack at BergdorfBio, available as a pre-formulated combination for research purposes.

Components and Synergy

GHK-Cu (Copper Tripeptide-1)

GHK-Cu is a tripeptide composed of glycine, histidine, and lysine, bound to a copper ion. This small molecule has an outsized biological effect: it upregulates genes involved in tissue repair while downregulating genes associated with inflammation and oxidative stress. In skin biology specifically, GHK-Cu:

• Stimulates fibroblast proliferation and collagen type I and III synthesis
• Promotes elastin production, improving skin firmness and reducing fine lines
• Activates matrix metalloproteinases (MMPs) to remove damaged collagen and replace it with new matrix
• Acts as a potent antioxidant, reducing lipid peroxidation and neutralizing free radicals
• Improves dermal density and hydration by supporting glycosaminoglycan synthesis
• Modulates over 4,000 human genes according to microarray studies

Studies have shown that topical and subcutaneous GHK-Cu can visibly reduce wrinkle depth and improve skin laxity within 8–12 weeks of consistent use. Its half-life is approximately 2 hours, which supports once-daily subcutaneous administration for systemic effect.

Learn more on the dedicated GHK-Cu calculator page or view the GHK-Cu product at BergdorfBio.

BPC-157 (Body Protection Compound-157)

BPC-157 is a pentadecapeptide (15 amino acids) derived from a naturally occurring protective protein in the gastric mucosa. Its stability and bioavailability make it one of the most studied tissue-repair peptides in preclinical research. In the context of the Glow Stack, BPC-157 contributes:

• Accelerated wound healing through upregulation of growth hormone receptor expression
• Angiogenesis (new blood vessel formation), which enhances nutrient delivery to skin tissue
• Reduction of systemic and local inflammation, which is a primary driver of skin aging
• Protection of fibroblasts and keratinocytes against oxidative damage
• Modulation of the nitric oxide (NO) system, supporting vascular function in dermis
• Neurological repair support, which may indirectly benefit skin quality via stress reduction pathways

BPC-157 has a half-life of approximately 4 hours and is typically administered once or twice daily. Its anti-inflammatory properties make it particularly valuable in the Glow Stack for addressing inflammation-driven skin degradation. Explore the BPC-157 calculator or view the BPC-157 product.

Synergistic Mechanism

The true power of the Glow Stack lies in the complementary action of these two peptides. GHK-Cu works primarily at the structural level — rebuilding extracellular matrix proteins and activating genetic programs for tissue renewal. BPC-157 operates through a different set of pathways, focusing on vascular growth, inflammation resolution, and cellular protection. When combined:

• BPC-157's angiogenic effect improves blood flow to the dermis, delivering more copper ions and nutrients that GHK-Cu requires for its enzymatic activity
• GHK-Cu's antioxidant action reduces the oxidative burden that would otherwise impair BPC-157's healing pathways
• The combined anti-inflammatory effect is greater than either peptide alone, addressing both the acute inflammation BPC-157 targets and the chronic low-grade oxidative inflammation GHK-Cu modulates
• Both peptides independently activate fibroblasts, creating a compounding stimulus for collagen and elastin production

Users of the Glow Stack typically report improvements in skin radiance and texture within 4–6 weeks, with more significant results in elasticity and wrinkle reduction visible after 8–12 weeks of consistent use.

Dosage Calculation

Calculating your dose for the Glow Stack requires knowing the concentration of your reconstituted vial. For a standard 10mg vial reconstituted with 2ml of bacteriostatic water (BAC water), the concentration is:

10mg / 2ml = 5mg/ml

This means every 1ml of solution contains 5mg of peptide. For the most common dose range of 0.5–2mg per day:

• 0.5mg dose: 0.5mg ÷ 5mg/ml = 0.10ml (10 units on a 100-unit insulin syringe)
• 1mg dose: 1mg ÷ 5mg/ml = 0.20ml (20 units)
• 1.5mg dose: 1.5mg ÷ 5mg/ml = 0.30ml (30 units)
• 2mg dose: 2mg ÷ 5mg/ml = 0.40ml (40 units)

You can calculate your precise injection volume using the Glow Stack calculator above — simply enter your vial size, BAC water volume, and desired dose to get the exact amount to draw.

If you are using a different BAC water volume (e.g., 1ml instead of 2ml), the formula adjusts accordingly:
Injection volume (ml) = Desired dose (mg) / Concentration (mg/ml)
Concentration (mg/ml) = Vial size (mg) / BAC water added (ml)

Dosing Protocol

The recommended starting approach for the Glow Stack is to begin at the lower end of the dose range and assess tolerance before titrating upward. A typical protocol for skin rejuvenation purposes follows:

Standard Protocol (Subcutaneous)

• Starting dose: 0.5mg once daily, administered subcutaneously
• Maintenance dose: 1–2mg once daily after 1–2 weeks of tolerance assessment
• Timing: Morning injection is preferred; some users prefer evening to align with overnight skin repair cycles
• Cycle length: 8–12 weeks on, 4 weeks off; repeat as needed
• Injection site: Subcutaneous fat of the abdomen (most common), thigh, or upper arm

Topical Protocol (Alternative)

Some users apply dissolved GHK-Cu topically to the face and neck while administering BPC-157 subcutaneously. If applying topically, a concentration of 1–2mg per ml in a carrier solution is typical. Topical application may be less effective for systemic anti-aging effects but can target specific areas more precisely.

Cycling Considerations

Because both peptides work through receptor-mediated pathways, cycling helps prevent receptor desensitization and maintains responsiveness. A standard on/off cycle of 2 months on and 4 weeks off is a commonly used approach. During the off period, some users continue a lower maintenance dose of GHK-Cu alone (0.5mg every other day) to maintain baseline skin support without full receptor loading.

Reconstitution

Reconstituting the Glow Stack peptide vial correctly is essential for accurate dosing and product stability. Follow these steps:

1. Gather supplies: 10mg Glow Stack vial, bacteriostatic water (BAC water), 1ml or 3ml syringe with needle, alcohol swabs
2. Sterilize: Wipe the rubber stopper of the peptide vial and the BAC water vial with alcohol swabs. Allow to dry for 30 seconds.
3. Draw BAC water: Draw 2ml of bacteriostatic water into the syringe.
4. Inject slowly: Insert the needle into the peptide vial at an angle. Let the BAC water run slowly down the inside wall of the vial — do not inject directly onto the powder, as this can denature the peptide.
5. Do not shake: Gently swirl or roll the vial between your palms until the powder dissolves completely. Never shake vigorously. Dissolution should take 30–60 seconds.
6. Inspect: The reconstituted solution should be clear and colorless. Discard if cloudy, particulate, or discolored.
7. Label: Mark the vial with the date of reconstitution and the concentration (5mg/ml).

Storage

Proper storage is critical to maintaining peptide potency and extending shelf life:

• Unreconstituted (lyophilized) vials: Store at room temperature (15–25°C / 59–77°F) away from light and moisture. For long-term storage (over 3 months), refrigerate at 2–8°C. Can be frozen at -20°C for up to 24 months without significant degradation.
• Reconstituted vials: Store at 2–8°C (refrigerator) in an upright position. Use within 28 days of reconstitution. Bacteriostatic water inhibits bacterial growth and extends the usable window compared to sterile water.
• Temperature stability: Avoid repeated freeze-thaw cycles. Do not expose reconstituted vials to temperatures above 25°C.
• Light sensitivity: GHK-Cu is moderately sensitive to UV light. Store vials in the original box or wrap in foil if storing for extended periods.
• Travel: Use a small insulated cooler with an ice pack for travel lasting more than a few hours. Most commercial insulated medication pouches maintain appropriate temperatures for 24–48 hours.

Side Effects and Safety Considerations

Both GHK-Cu and BPC-157 have well-established safety profiles in preclinical and clinical research. The Glow Stack is generally well-tolerated, but you should be aware of potential considerations:

Common and Minor

• Injection site reactions: Mild redness, swelling, or discomfort at the injection site is the most common side effect, typically resolving within hours. Rotate injection sites to minimize this.
• Temporary skin flushing: Some users report mild skin flushing or warmth, particularly when starting the protocol. This typically subsides after the first 1–2 weeks.
• Increased skin sensitivity: As collagen turnover accelerates, some users experience temporary increased sensitivity or mild irritation. Reducing dose or frequency usually resolves this.

Less Common

• Fatigue or mild lethargy: Reported by a minority of users during the first week, likely reflecting systemic adaptation. Usually resolves within days.
• Nausea: Rare, usually associated with higher doses. Starting at 0.5mg typically avoids this.
• Changes in skin pigmentation: GHK-Cu may temporarily affect melanin distribution in some users. This effect is reversible and typically resolves during the off-cycle.

Contraindications

• Do not use if you have a known allergy to copper or any component of the formulation
• Avoid during pregnancy and breastfeeding (insufficient safety data)
• Consult a physician if you have active cancer, as GHK-Cu's tissue growth-stimulating properties have not been studied in oncological contexts
• Individuals with Wilson's disease (copper metabolism disorder) should not use copper-containing peptides

Medical disclaimer: The Glow Stack is sold for research purposes only. This content is educational and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any peptide protocol.

Related Stacks and Peptides

If you are exploring the Glow Stack for skin health and anti-aging, the following related peptides and stacks may also be of interest:

• GHK-Cu — The primary collagen and elastin-stimulating component of the Glow Stack, also available as a standalone peptide. Ideal if you want to focus purely on copper peptide benefits. View GHK-Cu at BergdorfBio.
• BPC-157 — The tissue repair and anti-inflammatory component of the Glow Stack, also effective for gut health, joint repair, and injury recovery when used standalone. View BPC-157 at BergdorfBio.
• Klow Stack — An anti-aging blend targeting cellular regeneration and longevity at a deeper level than the Glow Stack. Often combined with or cycled alongside the Glow Stack for a comprehensive anti-aging approach. View Klow Stack at BergdorfBio.
• TB-500 — Thymosin Beta-4 supports systemic tissue repair and may complement the Glow Stack for users dealing with chronic inflammation affecting skin quality.
• SS-31 — Elamipretide targets mitochondrial protection, which pairs well with the Glow Stack for users seeking to address cellular energy decline as a driver of skin aging.

Frequently Asked Questions

How long does it take to see results with the Glow Stack?

Most users report initial improvements in skin hydration and overall radiance within the first 2–4 weeks. Structural changes such as improved elasticity, reduced fine lines, and better dermal density typically become visible between weeks 6–12. Maximum benefits are usually observed after a full 12-week cycle, with results continuing to improve during the off-period as newly synthesized collagen matures.

Can I inject GHK-Cu and BPC-157 in the same syringe?

Yes, if they are reconstituted separately, you can draw both into the same syringe immediately before injection to combine them into a single daily shot. Some users prefer keeping them in separate vials to maintain individual dose flexibility. Do not pre-mix and store a combined solution, as stability data for combined storage is not available.

Is the Glow Stack suitable for both men and women?

Yes. Both GHK-Cu and BPC-157 have no sex-specific mechanisms and have been studied across both sexes in preclinical models. The skin-rejuvenating benefits apply equally, though individual responses may vary. Some studies suggest women in the post-menopausal period may experience particularly pronounced benefits from GHK-Cu due to the accelerated collagen loss associated with estrogen decline.

Can the Glow Stack be applied topically instead of injected?

GHK-Cu has well-documented topical bioavailability and is the basis of many cosmetic serums. BPC-157 has less evidence for topical absorption due to its larger molecular weight. For the full synergistic benefit of the Glow Stack, subcutaneous administration delivers both peptides systemically. However, some users combine topical GHK-Cu application (dissolved in serum or carrier) with subcutaneous BPC-157 for a dual-route approach.

What syringe size should I use for the Glow Stack?

A 0.3ml (30-unit) insulin syringe with a 29–31 gauge, 8mm needle is recommended for most doses in the 0.5–2mg range. For doses above 1.5mg (0.30ml at 5mg/ml concentration), a 0.5ml syringe may be more comfortable. Use the shortest needle available for subcutaneous administration — 6–8mm is ideal for most injection sites.

Can I stack the Glow Stack with other peptides?

Yes. The Glow Stack is commonly combined with the Klow Stack for a more comprehensive anti-aging protocol. Some users also add SS-31 for mitochondrial support or TB-500 for enhanced tissue repair. When combining multiple peptide stacks, start one at a time to identify individual responses before adding additional compounds.

Does the Glow Stack interact with any medications?

No clinically documented drug interactions with GHK-Cu or BPC-157 have been established in the available literature. However, because BPC-157 modulates the nitric oxide system and prostaglandin pathways, theoretical interactions with NSAIDs, blood pressure medications, and nitrate drugs may exist. Always disclose all peptide use to your physician, particularly if you are on prescription medications.

How should I dispose of used syringes?

Used syringes and needles are sharps waste and must be disposed of in a puncture-resistant sharps container. Do not dispose of needles in regular household trash. Many pharmacies offer sharps disposal services, and some municipalities have sharps collection programs. Check local regulations for proper disposal methods in your area.